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The excitatory neurotransmitter glutamate has been reported to have a major impact
on brain energy metabolism. Using primary cultures of rat hippocampal neurons,
we observed that glutamate reduces glucose utilization in this cell type, suggesting
alteration in mitochondrial oxidative metabolism. The aquaglyceroporin AQP9 and the
monocarboxylate transporter MCT2, two transporters for oxidative energy substrates,
appear to be present in mitochondria of these neurons. Moreover, they not only
co-localize but they interact with each other as they were found to co-immunoprecipitate
from hippocampal neuron homogenates. Exposure of cultured hippocampal neurons to
glutamate 100μM for 1 h led to enhanced expression of both AQP9 and MCT2 at the
protein level without any significant change at the mRNA level. In parallel, a similar increase
in the protein expression of LDHA was evidenced without an effect on the mRNA level.
These data suggest that glutamate exerts an influence on neuronal energy metabolism
likely through a regulation of the expression of some key mitochondrial proteins.
Keywords: brain energy metabolism, mitochondria, lactate dehydrogenase, monocarboxylate transporter,
aquaglyceroporin
INTRODUCTION
The human brain represents only 2% of the total body weight
but it accounts for a much larger proportion of the total energy
expenditures of the organism (Magistretti, 1999). Under physi-
ological conditions, glucose is considered the major energy sub-
strate taken up and used by the adult brain to supply its energy
needs. A linear correlation between glucose utilization and brain
activity has been reported for various brain regions in different
conditions (Sokoloff, 1993). This tight relationship has formed
the basis for the development of some functional brain imaging
techniques (e.g., FDG-PET) to visualize changes in brain activ-
ity during cognitive tasks. Despite these important developments,
the specific fate of glucose at the cellular and molecular levels
remains elusive.
Glutamatergic synapses are by far the predominant type of
synapses in the central nervous system and constitute the main
source of excitatory neurotransmission. Glutamate enhances both
glucose transport (Loaiza et al., 2003) as well as uptake and
utilization (Pellerin and Magistretti, 1994, 1996a) in cultured
astrocytes. As a consequence, a major part of glucose uptake
taking place in an activated brain region and visualized by func-
tional brain imaging is due to astrocytic utilization (Pellerin and
Magistretti, 1996b, 2012; Figley and Stroman, 2011). Such a view
is reinforced by recent observations made ex vivo and in vivo.
First, it was demonstrated in cerebellar slices using fluorescent
glucose analogs that both glucose transport and metabolism
occur preferentially in Bergmann glia over Purkinje cells while
the same observation was made for astrocytes over neurons in
hippocampal slices (Barros et al., 2009; Jakoby et al., 2014). In
addition, it was shown in experiments performed in anesthetized
rats that whisker stimulation caused a significant increase of glu-
cose uptake in astrocytes, but not in neurons, in the activated
somatosensory cortex (Chuquet et al., 2010). While these data
indicate that a prominent part of glucose utilization take place
in astrocytes, they also suggest that active neurons must obtain
an alternative energy substrate to cover their enhanced energy
needs.
In addition to glucose, neurons are able to use a few alterna-
tive oxidative energy substrates that include monocarboxylates
such as lactate or the ketone bodies (Pellerin, 2010). The use
of these energy substrates by brain cells requires the presence
of specific transporters (Pierre and Pellerin, 2005). Indeed, neu-
rons predominantly express the high affinity monocarboxylate
transporter MCT2 (Bergersen et al., 2001; Pierre et al., 2002).
In addition, at least some populations of neurons also express
the aquaglyceroporin AQP9 (Badaut, 2010), a carrier known to
allow the passage not only of glycerol but also of lactate (Badaut
et al., 2007). So far, few informations exist about the relative
subcellular distribution of these two transporters in neurons as
well as the possible regulation of their expression in relation
with glutamatergic neurotransmission. In this study, we aimed to
determine (1) whether glutamate modulates glucose utilization
in rat hippocampal neurons, (2) if AQP9 and MCT2 can be co-
expressed by neuronal mitochondria, and (3) if glutamate could
alter the expression of AQP9 and/or MCT2 in the same neuronal
population.
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MATERIALS AND METHODS
HIPPOCAMPAL NEURONAL CULTURES
All animal experiments were performed in accordance with the
Swiss animal welfare laws under the authorization n◦ VD 1251.4
delivered by the Service de la consommation et des affaires
vétérinaires du Canton de Vaud, Switzerland. Hippocampi were
carefully dissected from E18Wistar rat embryos and then the cells
were placed in 0.25% Tripsin-EDTA buffer supplemented with
100mM of DNAse I. In order to stop the effect of trypsin, neu-
robasal culture medium with 1% fetal bovine serum was added
and then cells were mechanically dissociated by gentle passage
through fire-polished glass pipets. After centrifugation (5min,
300 g), pellets of dissociated cells were resuspended in neurobasal
culture medium supplemented with B27 (2%), L-glutamine
(0.5mM) and an antibiotic cocktail (Neugene, 0.5%). Viable cells
were counted using a Scepter Handheld Automatic Cell Counter
(Millipore, Billerica, USA). Cells were plated at a density of
1.5 × 105 cells/well on Poly-D-Lysine coated coverslips in 24-well
dishes containing 0.5mL of culture medium for immunofluo-
rescence experiments and 7.5 × 105 cells/well in Poly-D-Lysine
coated 6-well dishes containing 2ml of culture medium for the
other assays. Cells were maintained at 37◦C in a 5% CO2 atmo-
sphere, without any further changes.
CELL CULTURE STIMULATION PROCEDURES
After 6 days in vitro (DIV), cultured neurons were stimulated by
treatment with 100μM of L-glutamic acid for 1 h (Bliss et al.,
2004; Hartz et al., 2009). This treatment was used to mimic the
increased neuronal excitability that occurs during an ictal epilep-
tic episode (Churn et al., 1991; Blair et al., 2008; Hartz et al.,
2009).
[3H]2DG UPTAKE AND LACTATE RELEASE MEASUREMENT
Primary cultures of rat hippocampal neurons were used at con-
fluence, usually between 6 and 7 days after seeding. 2-Deoxy-D-
[1,2-3H]glucose ([3H]2DG) uptake was determined as described
previously (Pellerin and Magistretti, 1994). On the day of the
experiment, the culture medium was replaced by serum-free
DMEM supplemented with 5mM glucose, 44mM NaHCO3,
0.06 g/L penicillin, 0.1 g/L streptomycin, and 0.045mM phenol
red (DMEM5). Cultured hippocampal neurons were incubated
for 2 h at 37◦C in a water-saturated atmosphere containing 5%
CO2/95% air. The medium was then replaced by 2ml of the
same DMEM5 medium containing [3H]2DG at a concentration
of 1μCi/ml (33 nM). In order to study the effect of stimu-
lation in cultured cells, 100μM of glutamate were added to
the medium 1 h before substitution by the medium containing
[3H]2DG as well as 100μM glutamate and the cells were fur-
ther incubated for 20min in the same conditions as previously
indicated. The reaction was stopped by aspiration of the medium
followed by rinsing the cells three times with ice-cold phosphate
buffered saline and 0.1M NaOH/0.1% Triton X-100 was added
to lyse the cells. Aliquots of 500μl were assayed for radioac-
tivity by liquid scintillation counting, while 50μl aliquots were
used for measurement of protein by the method of Bradford
(1976). Results, which represent glucose transporter-mediated
uptake and subsequent phosphorylation, were calculated by
subtracting from total counts the portion that was not inhibited
by the glucose transporter inhibitor cytochalasin B (10μM). The
cytochalasin-sensitive uptake accounted for 80% of total uptake.
Lactate measurement was performed as previously described
(Pellerin and Magistretti, 1994). Briefly, supernatants from 2DG
uptake experiments were collected to determine lactate produc-
tion and release. Two 100μl aliquots for each supernatant were
placed in separate wells of a 96-well plate. To each well was added
100μl of a solution containing lactate dehydrogenase 70U/ml
(Sigma, Buchs, Switzerland) and NAD 15mM (Acros organics,
Geel, Belgium) in glycine-semicarbazide buffer 0.33M, pH 10.
After 1 hour at 37◦C, plates were read at 340 nm to detect pro-
duction of NADH. A standard curve with known concentrations
of lactate was used to determine lactate concentrations, corrected
for the amount of protein in the same culture well.
MITOTRACKER STAINING
The red Mitotracker® (Molecular Probes, Eugene, USA), a mito-
chondrial potential-sensitive dye, was added to the culture
medium of cultured hippocampal neurons at 6DIV at a con-
centration of 150 nM for 30min at 37◦C. Samples were washed
with PBS and fixed in 4% paraformaldehyde for further use in
immunolabeling and confocal fluorescence experiments.
ANTIBODIES
The commercial antibodies used in this work were anti-AQP9
(Santa Cruz Biotechnology, California, USA), anti-lactate dehy-
drogenase A, (Abcam, Cambridge, UK), and anti-β-tubulin
(Sigma, Buchs, Switzerland). The polyclonal anti-MCT2 antibody
is a previously characterized homemade antibody (Pierre et al.,
2000).
IMMUNOCYTOCHEMISTRY
Rat hippocampal neurons grown directly on coverslips were used
to perform immunofluorescence experiments. After removal of
the culture medium, cells were carefully rinsed in phosphate-
buffered saline (PBS) at 37◦C and directly postfixed in an ice-
cold paraformaldehyde fixative (PFA 4% in PBS for 30min
at 20◦C). Fixed cells were treated with casein (0.5% in PBS)
for 1h at room temperature to block non-specific sites. For
immunostaining, cultures were incubated overnight at 4◦C in
50μL of freshly prepared anti-MCT2 antibody solution [anti-
MCT2 diluted 1:50 (Pierre et al., 2000) in PBS containing 0.25%
bovine serum albumin] and/or with anti-AQP9 diluted 1:5 in
PBS containing 0.25% bovine serum albumin. After carefully
rinsing in PBS, cultures were incubated for 2 h at room tem-
perature in a solution containing Cy3-conjugated anti-rabbit
IgG or FITC-conjugated anti-goat IgG (diluted 1:250; Jackson
Immunoresearch, Baltimore, USA). After rinsing in PBS twice
and a final rinsing in water, coverslips were mounted with
Vectashield containing DAPI (Reactolab SA, Burlingame, CA,
USA). Coverslips containing the cells were examined and pho-
tographed using a LSM 710 Quasar Confocal Microscope (Zeiss,
Hallbergmoos, Germany). Images were obtained using a Plan
Apochromat 63× objective and acquired using a cooled CCD
camera (Axiocam, Zeiss, Hallbergmoos, Germany), together with
the Zeiss 2009 software (Zeiss, Hallbergmoos, Germany). Five
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neurons were randomly chosen on each coverslip. Pictures were
then analyzed using the plugin WCIF-ImageJ for co-localization
analysis for ImageJ NIH software (National Institutes of Health
Image program, version 1.62, Rockville Pike, USA). Images were
converted to 8-bit images for each red and green label of each
image, and then the level of co-localization was determined
by Mander’s overlap coefficient, and the data are presented as
percentage of co-localization.
ELECTROPHORESIS ANDWESTERN BLOTTING
Rat hippocampal neurons in each culture dish were homoge-
nized in 500μL of lysis buffer containing the following: Tris-
HCl, pH 6.8, 80mmol/L; EDTA (ethylene diamine tetraacetic
acid), 5mmol/L; NP-40, 1% or SDS, 5% and a mixture of
protease inhibitors (Complete, Roche Molecular Biochemicals,
Mannheim, Germany). Control and each stimulated condition
were performed in triplicate. Protein samples from rat hippocam-
pal neuronal cultures were sonicated and heated at 95◦C for
5min in half the final volume of SDS-PAGE sample buffer (Tris-
HCl, 62.5mmol/L; DTT, 50mmol/L; SDS, 2%; glycerol, 10%;
and bromophenol blue, 0.1%). Samples were loaded onto poly-
acrylamide gels composed of a 4.5% acrylamide-bisacrylamide
stacking gel and a 12% acrylamide-bisacrylamide running gel.
After electrophoresis, proteins were transferred onto nitrocellu-
lose membranes (Trans-Blot Transfer Medium 162-0115; Bio-
Rad, Reinach, Switzerland) using a Transblot semi-dry transfer
cell (Bio-Rad, Reinach, Switzerland). For protein detection, mem-
branes were incubated in a blocking solution of Tris-buffered
saline supplemented with Tween-20 (TBST; Tris-HCl, pH 7.5,
50mmol/L; NaCl, 150mmol/L; and Tween-20, 0.1%) contain-
ing 5% non-fat milk for 1 h at room temperature. Membranes
were incubated overnight at 4◦C in a solution containing the
primary antibody. After washing in TBST, membranes were
incubated with horseradish peroxidase (HRP) conjugated sec-
ondary antibodies in TBST containing 1% of non-fat milk, for
2 h at room temperature. After washing in TBST, membranes
were submitted to a chemiluminescent reaction using ECL (GE
Healthcare, Ecublens, Switzerland), and then photographed using
the ChemiDoc XRS + (BioRad). Quantification was made using
ImageJ software (NIH, Maryland, USA).
IMMUNOPRECIPITATION
Primary cultures of rat hippocampal neurons were collected and
homogenized in ice-cold lysis buffer containing 20mM Tris HCl;
137mM NaCl; 10% Glycerol; 1% n-octyl-b-D-glucoside (OG)
and 2mM EDTA, pH 7.4, in presence of a complete set of
protease inhibitors (Complete; Roche Molecular Biochemicals,
Mannheim, Germany) and the homogenate was sonicated three
times for 5 s each. The homogenate was reacted with the primary
antibody (1:50 anti-MCT2) overnight at 4◦C. Agarose-conjugated
protein A was added and incubated with gentle rocking at 4◦C for
2 h. This complex was then centrifuged at 14,000 g during 30 s at
4◦C and washed five times with ice-cold lysis buffer. The pellet
was then resuspended in 3× SDS sample buffer and microcen-
trifuged for 30 s. The sample was heated to 95–100◦C for 5min
and centrifuged for 1min at 14,000 g. The supernatant was col-
lected, loaded on SDS-PAGE and Western blot was performed
as described above to verify the presence of AQP9 in the MCT2
immunoprecipitate. Total protein extract from primary cultures
of rat hippocampal neurons was loaded as control for each
experiment.
QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION
Quantitative determination of AQP9, MCT2, and LDHA mRNA
expression levels was performed by quantitative Real-Time
Polymerase Chain Reaction (qRT-PCR) according to Heid et al.
(1996) using a StepOnePlus or ViiA 7 sequence detection system
from Applied Biosystems (Rotkreuz, Switzerland). The follow-
ing sets of oligonucleotides (Microsynth, Balgach, Switzerland)
were used: ActinFo, CTTCTTTGCAGCTCCTTCGT; ActinRe,
ATATCGTCATCCATGGCGAAC (Embl: X03672); MCT2Fo, CA
GCAACAGCGTGATAGAGCTT;MCT2Re, TGGTTGCAGGTTG
AATGCTAAT (Embl: NM_017302); AQP9Fo, GATGGACTCA
FIGURE 1 | Effect of glutamate on glucose utilization and lactate
production in cultured rat hippocampal neurons. (A)
[3H]-2-deoxyglucose uptake and accumulation was measured in primary
cultures of rat hippocampal neurons for 20min either without exposure to
glutamate (Ctrl) or with prior treatment with glutamate 100μM for 1 h
followed by the presence of the same concentration of glutamate during
the [3H]2DG uptake measurement (Glut100). (B) Lactate production and
release was measured in primary cultures of rat hippocampal neurons for
20min either without exposure to glutamate (Ctrl) or with prior treatment
with glutamate 100μM for 1 h followed by the presence of the same
concentration of glutamate during the lactate production measurement
(Glut100). Data represent mean ± SD with n = 3. Statistical analysis was
performed using a non-parametric Mann–Whitney test. An asterisk
indicates 2DG uptake significantly different from control with p < 0.05.
2DG, 2-Deoxyglucose; CTRL, Control.
www.frontiersin.org August 2014 | Volume 8 | Article 246 | 3
Tescarollo et al. AQP9 and MCT2 in neurons
TGGCCTTTGCTG; AQP9Re, CAATCATAGGACCCACGACA
GG (Embl: NM_022960.2); LDHAFo, TGGCCTCTCCGTGG
CAGACT; LDHARe, CCCCCAGACCACCTCAACACAA (Embl:
NM_017025.1).
STATISTICAL ANALYSIS
Experimental data are expressed as mean ± standard deviation
(SD). They were statistically analyzed with a non-parametric
Mann–Whitney test. Statistical significance was set at p < 0.05.
RESULTS
Glucose utilization of cultured hippocampal neurons in
response to glutamate stimulation was evaluated by measuring
3H-2-deoxyglucose (2DG) uptake. Treatment of cultured
hippocampal neurons with glutamate 100μM for 1 h induced a
significant decrease in 2DG uptake (−11.74 ± 3.7%) compared
to the control group (Figure 1A). In parallel, measurement
of lactate accumulated in the medium did not reveal any
significant difference, arguing against a reduction in gly-
colytic flux ending with lactate production (Figure 1B).
Such an unexpected effect of glutamate on glucose utiliza-
tion in neurons suggested that some modifications, notably
on oxidative metabolism, might take place in these cells
following an exposure to glutamate. For this reason, the
expression of the aquaglyceroporin AQP9 and the mono-
carboxylate transporter MCT2 which are involved in the
transport of oxidative substrates was investigated in this
preparation.
FIGURE 2 | Immunofluorescent localization of AQP9 and MCT2 in
mitochondria of cultured rat hippocampal neurons (A) Immuno
fluorescent labelings for AQP9 (in green, upper row) or MCT2 (in green,
bottom row) and mitotracker staining (in red) in cultured rat
hippocampal neurons. Colocalization between AQP9 or MCT2 and
mitotracker appears as yellow on merged images (Merge). Nuclei (in blue)
were labeled using Hoechst staining. (B) Quantification of the degree of
colocalization between AQP9 or MCT2 and mitotracker. The degree of
colocalization was assessed with Mander’s overlap coefficient obtained by
using the plugin WCIF-ImageJ for colocalization analysis for ImageJ NIH
software. Immunofluorescence was visualized using confocal microscopy
with appropriate filters. Data represent mean ± SD with n = 5.
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Double labelings with a mitochondrial marker, the
MitoTracker®, and either MCT2 or AQP9 were performed
on cultured hippocampal neurons and analyzed by confocal
microscopy (Figure 2). Observation of fluorescence images
revealed that co-localization was present for both AQP9
and MCT2 (Figure 2A). Quantification of the degree of co-
localization revealed that it reaches 83.2 ± 7.1% between AQP9
and the mitochondrial marker while it was of 85.2 ± 6.2% for
MCT2 and the same mitochondrial marker (Figure 2B).
Such a similar degree of co-localization with the same mito-
chondrial marker suggested that AQP9 and MCT2 could co-
localize together. Indeed, using double immunofluorescence
labeling and confocal microscopy, it could be observed that
AQP9 and MCT2 shared a similar subcellular distribution in
cultured hippocampal neurons (Figure 3A). Quantification of
the level of co-localization between MCT2 and AQP9 stain-
ing in these neurons yielded a value of 83.0 ± 4.5%. Such a
high degree of co-localization raised the possibility of a closer
interaction between the two proteins. In order to determine
whether MCT2 interacts with AQP9 protein, MCT2 was
immunoprecipitated from total homogenates of cultured hip-
pocampal cells, protein fractions obtained fromMCT2 immuno-
precipitates were separated by electrophoresis and analyzed
for the presence of AQP9 by western blotting. Results show
that AQP9 is indeed detected in the MCT2 immunoprecipitate
(Figure 3B), indicating that AQP9 and MCT2 are linked to each
other.
The possibility that the level of expression of these two
energetic substrate transporters could be regulated by gluta-
mate has been investigated in rat hippocampal cultured neurons.
In parallel, the expression of the isoform A of lactate dehy-
drogenase, a key enzyme for the use of lactate as oxidative
substrate, was also determined. First, exposure of cultured hip-
pocampal neurons to glutamate (100μM) for 1 h caused no
significant change in the expression level of either AQP9, MCT2,
or LDHA (Figure 4A). A similar analysis was performed at the
protein level. In this case, it could be observed by Western
blot that AQP9, MCT2, and LDHA protein expression was
enhanced in cultured hippocampal neurons after exposure for 1 h
to glutamate 100μM (Figure 4B, upper panel). Quantification
of the level of expression revealed increases of 25.3 ± 1.46%
(AQP9), 29.9 ± 1.98% (MCT2), and 50.33 ± 3.93% (LDHA)
when compared to control.
DISCUSSION
Glutamate is the main excitatory neurotransmitter in the cen-
tral nervous system. It is purported that its depolarizing action
on neurons should lead to increased energy demands in this cell
FIGURE 3 | Colocalization and interaction between AQP9 and MCT2 in
cultured rat hippocampal neurons (A) Double immunofluorescence
labeling for AQP9 (in green) and MCT2 (in red) performed in cultured
hippocampal neurons. Colocalization between AQP9 and MCT2 appears as
yellow on the merged image (Merge). Nuclei (in blue) were labeled using
Hoechst staining. Immunofluorescence was visualized using confocal
microscopy with appropriate filters. (B) Western blot for AQP9 in cultured
hippocampal neuron protein extract after immunoprecipitation with
anti-MCT2 antibody (IP MCT2) or in total protein extract. This experiment was
repeated twice from separate cultures with similar results.
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FIGURE 4 | Effect of glutamate on mRNA and protein expression of
AQP9, MCT2, and LDHA in cultured rat hippocampal neurons (A)
Primary cultures of rat hippocampal neurons were treated with
glutamate 100µM for 1h. Then mRNA was extracted and analyzed for
AQP9, MCT2 and LDH mRNA expression using RT-PCR. Results are
expressed as relative expression vs. control with mean value for control
set at 1 after values had been normalized using β-actin as internal
reference. Results represent mean ± SD with n = 3. The experiment
was repeated three times from different cultures with similar results.
Statistical analysis was performed using a non-parametric Mann–Whitney
test. No significant difference was observed. (B) Primary cultures of rat
hippocampal neurons were treated with glutamate 100μM for 1 h. Then
proteins were extracted and analyzed for AQP9, MCT2, and LDH protein
expression using Western blot. Blot pictures were obtained with Bio-Rad
Chemidoc™ XRS system (BioRad, Cressier, Switzerland) and quantified
using ImageJ software. Quantitative results are expressed as percentage
of control after the values had been normalized using β-tubulin signal as
reference. Results represent mean ± SD with n = 3. The experiment
was repeated three times from different cultures with similar results.
Statistical analysis was performed using a non-parametric Mann–Whitney
test. An asterisk indicates protein level significantly different from control
with p < 0.05.
type. Indeed, it was reported that activation of NMDA receptors
(a subtype of glutamate receptors) causes an increase of glucose
utilization in cerebellar neurons (Bak et al., 2009). In contrast,
exposure of rat hippocampal neurons to glutamate induced a
decrease in glucose transport (Porras et al., 2004). Our data show-
ing a decrease in glucose utilization in rat hippocampal neurons
after exposure to glutamate are consistent with the study of Porras
et al. Although the contradictory results between the finding of
Bak et al. on one hand, and ours as well as the study of Porras
et al. on the other hand could be explained by the use of a differ-
ent preparation of neurons (cerebellar vs. hippocampal) as well as
by different stimulation conditions (brief NMDA applications in
Mg-free medium for Bak et al. vs. constant glutamate application
at 500μM for Porras et al. or 100μM for us), other reasons can
be invoked. Thus, it was recently shown that activation of NMDA
receptors in rat cortical neurons led to an enhancement of glycol-
ysis at the expense of the pentose phosphate shunt (Rodriguez-
Rodriguez et al., 2012). Such an effect, which is due to the
stabilization of the enzyme 6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase-3 (PFKFB3), a key regulator of glycolysis,
eventually causes oxidative stress, and cell death (Rodriguez-
Rodriguez et al., 2013). Based on these results, it can be concluded
that specific NMDA receptor activation enhances glucose uti-
lization in neurons by activating glycolysis (with the risk of
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inducing cell death later on) while glutamate exposure (which
can activate several subtypes of glutamate receptors in parallel)
rather leads to reduced glucose utilization by an as yet unknown
mechanism.
If we consider that glucose utilization and glycolysis could
be reduced upon physiological stimulation with glutamate, then
neurons must rely on another energy substrate to face the
enhanced energy demands caused by glutamate-dependent depo-
larization. One possibility could be to use monocarboxylates
such as lactate, pyruvate, or the ketone bodies β-hydroxybutyrate
and acetoacetate. Indeed, it was previously shown that neu-
rons preferentially use lactate over glucose-derived pyruvate as
preferential oxidative energy substrate, both in vitro (Bouzier-
Sore et al., 2003, 2006) and in vivo (Tyson et al., 2003; Serres
et al., 2004, 2005; Gallagher et al., 2009; Boumezbeur et al.,
2010; Wyss et al., 2011). In order to favor monocarboxylate
utilization, specific transporters must be present. It was previ-
ously shown that MCT2 is the predominant neuronal monocar-
boxylate transporter (Bergersen et al., 2001; Pierre et al., 2002).
MCT2 was found to be particularly enriched in dendrites, not
only at the plasma membrane associated with the postsynap-
tic density but also in an intracellular pool (Pierre et al., 2009).
Moreover, its subcellular distribution was shown to be altered
by various stimuli including glutamate, leading to enhanced lac-
tate uptake (Pierre et al., 2009). In parallel, the presence of the
aquaglyceroporin AQP9, which can transport small oxidative
subtrates such as lactate or glycerol, has been reported in neu-
rons. Thus, its expression was described in some populations of
neurons such as catecholaminergic (Badaut et al., 2004) as well
as hippocampal and cortical neurons (Mylonakou et al., 2009;
Arciénega et al., 2010). The presence of both MCT2 and AQP9
in neuronal mitochondria has been documented. In rat brain
sections, MCT2 was found to co-localize with cytochrome oxi-
dase in the inner membrane of neuronal mitochondria in the
cortex, the hippocampus and the thalamus (Hashimoto et al.,
2008). Similarly, AQP9 was found to be present in brain mito-
chondrial inner membranes (Amiry-Moghaddam et al., 2005)
although the presence of AQP9 in mitochondria has been dis-
puted (Yang et al., 2006). Our results not only confirm that both
MCT2 and AQP9 are present in rat hippocampal neuron mito-
chondria, but they also co-localize and co-immunoprecipitate.
These results suggest that both transporters are probably part
of a mitochondrial complex that facilitates the entry and use of
oxidative substrates. Our observation that glutamate enhances
the expression of both MCT2 and AQP9 expression would be
consistent with idea that to face enhanced energy demands, neu-
rons would favor the use of extracellular monocarboxylates as
oxidative substrates in mitochondria at the expense of glucose.
In our case, it could be pyruvate which is present in the culture
medium.
Interestingly, the expression of both MCT2 and AQP9 pro-
teins together with the LDHA protein was enhanced after
treatment with glutamate, while no change in mRNA expres-
sion for all three genes was detected. This observation sug-
gests that a coordinated translational regulation occurs for
these three proteins, reinforcing the view that they might form
together a complex within mitochondria, as suggested before
for MCT2 and LDH (Hashimoto et al., 2008). Previously, it
was shown that MCT2 is subject to translational regulation in
mouse cortical neurons when treated with different neuroac-
tive substances (Pierre et al., 2003; Chenal and Pellerin, 2007;
Chenal et al., 2008; Robinet and Pellerin, 2010). However, it
is the first time that both AQP9 and LDHA are shown to
undergo a similar regulation in cultured neurons. One pos-
sible explanation for the concomitant upregulation of these
three mitochondrial proteins by glutamate could be to facili-
tate the use of oxidative substrates other than glucose (as glu-
cose utilization is decreased under such conditions) in order
to face the increased energy demands imposed by excitation.
Nevertheless, it remains to be demonstrated whether the oxida-
tion of monocarboxylates and/or glycerol are enhanced under
these conditions.
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